The Asthma Urgency Shifting the Rescue Paradigm: A Call-to-Action Miniseries

Episode 1: The Limitations of Bronchodilator Only Rescue Therapy

Host: Gerald B. Lee, MD, FACAAI

Experts: William C. Anderson III, MD, FACAAI, Alan P. Baptist, MD, MPH, FACAAI

Asthma exacerbations continue to affect over 40% of asthma patients, which not only disrupts their quality of life but can lead to permanent loss of lung function. The goal of this podcast miniseries is to review why an anti-inflammatory reliever has become the standard of care in asthma management and to provide tips on how to implement this therapy into your practice! Topics include: pathophysiology, exacerbations, anti-inflammatory reliever (AIR), SMART therapy.

Learning Objectives:

• Expose the prevalence of asthma and exacerbations in the US

Reference:

Lee JJ, Baptist AP, Blake KV. Lack of awareness and knowledge of NHLBI 2020 Asthma Focused Updates. J Allergy Clin Immunol Pract. 2024 Jan;12(1):226-228.e2. doi: 10.1016/j.jaip.2023.09.035. Epub 2023 Oct 5. PMID: 37802252.

Speaker Disclosures:

Gerald B. Lee, MD, FACAAI

No relevant financial relationships with ineligible companies to disclose

William C. Anderson III, MD, FACAAI

Advisor: Genentech, Regeneron, Sanofi

Alan P. Baptist, MD, MPH, FACAAI

Advisor: AstraZeneca, GlaxoSmithKline, Regeneron, Sanofi

Researcher: AstraZeneca, Novartis, Regeneron

This podcast miniseries is supported by a grant from AstraZeneca.